TGFB1 and neoplasm: In the current study, we also found that the level of TGFβ1 in CAFs was associated with the prognosis of patients with SCLC, and tumor cell progression, multivariate analyses indicated that TGFβ1 was an independent indicator for prognosis in all cohorts.